3 ms·
> it doesn't seem like the BOM is the main factor in the price of existing CGMs anyway No. A huge reason for the cost is (1) costs in R&D but also (2) the cust
by vineyardmike 1y ago
> it doesn't seem like the BOM is the main factor in the price of existing CGMs anyway
No. A huge reason for the cost is (1) costs in R&D but also (2) the customer service/replacement requirements/etc required for medical devices.
If you were diabetic, and had a prescription for these devices, you'd be able to call Abott/Dexcom and get a replacement to a failed device shipped to you overnight. If the device didn't last the fully spec'd lifespan, you'd be eligible for replacements... etc
- mlsu 1y agoAnd on R&D; the QC bar for software and manufacturing is much higher. Every process has validation testing. So it is expensive both in R&D and manufacturing. Another thing is that these off the shelf CGMs don't really differ in quality to their prescription only counterparts, which have a pretty extreme risk profile (patient death or hospitalization if it spits out the wrong number). They use the same parts so those costs are inherited.